Table 1. Sample cohorts.
| Cohort 1 | Cohort 2 | Cohort 3 | Total | |
|---|---|---|---|---|
| Total Samples | 49 | 32 | 66 | 147 |
| Mucinous | 25 (51%) | 26 (81%) | 55 (83%) | 106 |
| Type | ||||
| IPMN | 17 | 20 | 35 | 72 |
| MCN | 8 | 6 | 19 | 33 |
| Other | - | - | 1 | 1 |
| Collection Site | ||||
| UM | 1 | 0 | 0 | 1 |
| UPMC | 22 | 26 | 0 | 48 |
| MSKCC | 2 | 0 | 55 | 57 |
| Non-mucinous | 24 (49%) | 6 (19%) | 11 (17%) | 41 |
| Type | ||||
| PC | 17 | - | - | 17 |
| SC | 2 | 2 | 11 | 15 |
| NET | 5 | 3 | - | 8 |
| Retention | - | 1 | - | 1 |
| Collection Site | ||||
| UM | 1 | 0 | 0 | 1 |
| UPMC | 22 | 6 | 0 | 28 |
| MSKCC | 1 | 0 | 11 | 12 |
IPMN, intraductal papillary mucinous neoplasm; MCN, mucinous cystic neoplasm; PC, pseudocyst; SC, serous cystadenoma; NET, neuroendocrine tumor; UM, University of Michigan; UPMC, University of Pittsburgh Medical Center; MSKCC, Memorial Sloan Kettering Cancer Center.